Similar articles

• [New trends in the treatment of moderate arterial hypertension].

  Tomov I. Tomov I. Vutr Boles. 1986;25(1):7-16. Vutr Boles. 1986. PMID: 2872752 Review. Bulgarian. No abstract available.
• The emerging problem of plasma lipid changes during antihypertensive therapy.

  Johnson BF. Johnson BF. J Cardiovasc Pharmacol. 1982;4 Suppl 2:S213-21. J Cardiovasc Pharmacol. 1982. PMID: 6177959 Review.
• Antihypertensive treatment and serum lipoproteins.

  Weidmann P, Uehlinger DE, Gerber A. Weidmann P, et al. J Hypertens. 1985 Aug;3(4):297-306. doi: 10.1097/00004872-198508000-00001. J Hypertens. 1985. PMID: 2864373 Review. No abstract available.
• The impact on serum lipids of combinations of diuretics and beta-blockers and of beta-blockers alone.

  Helgeland A. Helgeland A. J Cardiovasc Pharmacol. 1984;6 Suppl 3:S474-6. J Cardiovasc Pharmacol. 1984. PMID: 6208414
• Serum lipoproteins during treatment with antihypertensive drugs.

  Weidmann P, de Courten M, Ferrari P, Böhlen L. Weidmann P, et al. J Cardiovasc Pharmacol. 1993;22 Suppl 6:S98-105. J Cardiovasc Pharmacol. 1993. PMID: 7508069 Review.